Oppenheimer on OnKure Therapeutics Inc. (OKUR): we like the pivot toward PI3Ka programs
Tweet Send to a Friend
Oppenheimer analyst Matt Biegler reiterated an Outperform rating and $30.00 price target on OnKure Therapeutics Inc. (NASDAQ: OKUR)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
